Chromatin modification influences gene expression by either repressing or activating genes, depending on the specific histone mark. Chromatin structure can also influence alternative splicing of transcripts; however, the mechanisms by which epigenetic marks influence splicing are poorly understood. A report in the current issue of the JCI highlights the biological importance of the coordinated control of alternative pre-mRNA splicing by chromatin structure and transcriptional elongation. Yuan et al. found that mutation of the histone methyl transferase SEDT2 affects alternative splicing fates of several key regulatory genes, including those involved in Wnt signaling. As a consequence, loss of SEDT2 in the intestine aggravated Wnt/β-catenin signaling effects, thereby leading to colorectal cancer.
Alberto R. Kornblihtt
Title and authors | Publication | Year |
---|---|---|
The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer
Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G, Zhang Y, Li B |
Cell Death & Disease | 2025 |
PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Chang Z, Jia Y, Gao M, Song L, Zhang W, Zhao R, Yu D, Liu X, Li J, Qin Y |
Biology direct | 2024 |
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation
Venkatasubramanian M, Schwartz L, Ramachandra N, Bennett J, Subramanian KR, Chen X, Gordon-Mitchell S, Fromowitz A, Pradhan K, Shechter D, Sahu S, Heiser D, Scherle P, Chetal K, Kulkarni A, Myers KC, Weirauch MT, Grimes HL, Starczynowski DT, Verma A, Salomonis N |
2024 | |
SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL
Liu C, Ni L, Li X, Rao H, Feng W, Zhu Y, Zhang W, Ma C, Xu Y, Gui L, Wang Z, Aji R, Xu J, Gao W, Li L |
Clinical and Translational Medicine | 2023 |
Alternative Splicing in Cancer and Immune Cells
A Bernard, R Boidot, F Végran |
Cancers | 2022 |
Crosstalk between macrophage-derived PGE2 and tumor UHRF1 drives hepatocellular carcinoma progression
Zhang J, Zhang H, Ding X, Hu J, Li Y, Zhang J, Wang H, Qi S, Xie A, Shi J, Xiang M, Bin Y, Wang G, Wang L, Wang Z |
Theranostics | 2022 |
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
Volovat SR, Augustin I, Zob D, Boboc D, Amurariti F, Volovat C, Stefanescu C, Stolniceanu CR, Ciocoiu M, Dumitras EA, Danciu M, Apostol DG, Drug V, Shurbaji SA, Coca LG, Leon F, Iftene A, Herghelegiu PC |
Cancers | 2022 |
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
K Kitamura, K Nimura |
Cells | 2021 |
Prognostic alternative splicing signature in cervical squamous cell carcinoma
H Wu, Q Li, L Liang, L Qiu, H Wei, B Huang, C Gang-, R He, Z Huang, W Hou, Q Hu, S Pan |
IET Systems Biology | 2020 |
The HNRNPA2B1–MST1R–Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer
A Gupta, S Yadav, A PT, J Mishra, A Samaiya, RK Panday, S Shukla |
Laboratory Investigation | 2020 |
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data
HY Wu, ZG Peng, RQ He, B Luo, J Ma, XH Hu, YW Dang, G Chen, SL Pan |
International journal of oncology | 2019 |
Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
HY Wu, Y Wei, LM Liu, ZB Chen, QP Hu, SL Pan |
Oncology Letters | 2019 |
Histone Modifications and their Role in Colorectal Cancer (Review)
J Qin, B Wen, Y Liang, W Yu, H Li |
Pathology & Oncology Research | 2019 |
Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
WJ Ma, X Wang, WT Yan, ZG Zhou, ZZ Pan, G Chen, RX Zhang |
World journal of gastroenterology : WJG | 2018 |